The new drug list includes 36 newly negotiated drugs, of which 15 is a targeted drug for the treatment of malignant tumors. It covers lung cancer, liver cancer, breast cancer, kidney cancer and other malignant tumor diseases. Targeted drugs have good therapeutic effects and high prices, and they were not reimbursed before. It is really good news for cancer patients to be included in the list of medical insurance drugs in Beijing through national negotiations.
Through national negotiations, the overall drug price has dropped by an average of 40%, with the highest drop of 70%. Take drugs to treat breast cancer. It turns out that the patient's drug cost is more than 20 thousand yuan per month, which is about 250 thousand yuan a year. Through national negotiations, the drug price has dropped to more than 7,000 yuan per month, and the personal burden is less after reimbursement.
Legal basis: People's Republic of China (PRC) Social Insurance Law.
Twenty-third employees should participate in the basic medical insurance for employees, and employers and employees should pay the basic medical insurance premiums in accordance with state regulations.
Individual industrial and commercial households without employees, part-time employees who have not participated in the basic medical insurance for employees and other flexible employees can participate in the basic medical insurance for employees, and individuals pay the basic medical insurance premium in accordance with state regulations.
Article 24 The state establishes and improves the new rural cooperative medical system.
Measures for the administration of the new rural cooperative medical system shall be formulated by the State Council.